Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10013213HBVENSG00000126218.12protein_codingF10NoNo2159P00742
Q5JVE7
Q5JVE8
TVIS10020895HBVENSG00000126218.12protein_codingF10NoNo2159P00742
Q5JVE7
Q5JVE8
TVIS30020164HIVENSG00000126218.12protein_codingF10NoNo2159P00742
Q5JVE7
Q5JVE8
TCGA Plot Options
Drug Information
GeneF10
DrugBank IDDB01109
Drug NameHeparin
Target IDBE0000216
UniProt IDP00742
Regulation Typeinhibitor
PubMed IDs17118432; 17004727; 11369259; 3155697
CitationsIgnjatovic V, Summerhayes R, Gan A, Than J, Chan A, Cochrane A, Bennett M, Horton S, Shann F, Lane G, Ross-Smith M, Monagle P: Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate? Thromb Res. 2007;120(3):347-51. Epub 2006 Nov 21.@@Patey SJ, Edwards EA, Yates EA, Turnbull JE: Heparin derivatives as inhibitors of BACE-1, the Alzheimer's beta-secretase, with reduced activity against factor Xa and other proteases. J Med Chem. 2006 Oct 5;49(20):6129-32.@@Rezaie AR: Heparin-binding exosite of factor Xa. Trends Cardiovasc Med. 2000 Nov;10(8):333-8.@@Rosenberg RD: Role of heparin and heparinlike molecules in thrombosis and atherosclerosis. Fed Proc. 1985 Feb;44(2):404-9.
GroupsApproved; Investigational
Direct Classification
SMILES
PathwaysFc Epsilon Receptor I Signaling in Mast Cells; Heparin Action Pathway
PharmGKBPA449855
ChEMBLCHEMBL1909300